ASX Announcement Chair and Deputy Chair Appointments Melbourne, Australia; 1 October 2026: On behalf of the Board of Directors, Starpharma (ASX: SPL, US OTC: SPHRY) today announces that, as previously foreshadowed, Mr Rob Thomas AO will retire as Chair of the Board at the conclusion of the 2026...
Chair and Deputy Chair Appointments
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Ceasing to be a substantial holder
- Becoming a substantial holder
- Annual General Meeting 2026 Date
- S&P DJI Announces September 2026 Quarterly Rebalance
- FY26 Key Financial Results and Annual Report
Later from Starpharma
- Notification of cessation of securities - SPL
- Application for quotation of securities - SPL
- Change of Director's Interest Notice - C Maley
- Notice of Annual General Meeting/Proxy Form
- Change in substantial holding
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma